

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 9.91604060 |
| 2 | regulation of isotype switching to IgG isotypes (GO:0048302) | 9.41480218 |
| 3 | regulation of podosome assembly (GO:0071801) | 9.40003273 |
| 4 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 8.67402926 |
| 5 | positive regulation of humoral immune response (GO:0002922) | 8.44184784 |
| 6 | positive regulation of immune response to tumor cell (GO:0002839) | 7.89112096 |
| 7 | regulation of immune response to tumor cell (GO:0002837) | 7.89112096 |
| 8 | regulation of response to tumor cell (GO:0002834) | 7.89112096 |
| 9 | positive regulation of response to tumor cell (GO:0002836) | 7.89112096 |
| 10 | activated T cell proliferation (GO:0050798) | 7.83585220 |
| 11 | * positive regulation of B cell mediated immunity (GO:0002714) | 7.76939472 |
| 12 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 7.76939472 |
| 13 | positive regulation of isotype switching (GO:0045830) | 7.28679982 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 7.21516197 |
| 15 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 7.18814697 |
| 16 | regulation of chronic inflammatory response (GO:0002676) | 6.93005068 |
| 17 | interferon-gamma production (GO:0032609) | 6.84584183 |
| 18 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 6.79532760 |
| 19 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 6.30198457 |
| 20 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 6.30198457 |
| 21 | positive regulation of DNA recombination (GO:0045911) | 6.17730619 |
| 22 | regulation of regulatory T cell differentiation (GO:0045589) | 6.09391845 |
| 23 | myeloid dendritic cell differentiation (GO:0043011) | 6.04169264 |
| 24 | regulation of RIG-I signaling pathway (GO:0039535) | 6.00093063 |
| 25 | * regulation of immunoglobulin mediated immune response (GO:0002889) | 5.93748897 |
| 26 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.84790645 |
| 27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.84790645 |
| 28 | DNA deamination (GO:0045006) | 5.83040116 |
| 29 | * regulation of B cell mediated immunity (GO:0002712) | 5.72757065 |
| 30 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.44475297 |
| 31 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.41581980 |
| 32 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.41581980 |
| 33 | cytidine metabolic process (GO:0046087) | 5.34456501 |
| 34 | cytidine catabolic process (GO:0006216) | 5.34456501 |
| 35 | cytidine deamination (GO:0009972) | 5.34456501 |
| 36 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.33770388 |
| 37 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 5.29937311 |
| 38 | regulation of growth of symbiont in host (GO:0044126) | 5.29937311 |
| 39 | negative regulation of growth of symbiont in host (GO:0044130) | 5.29937311 |
| 40 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 5.29937311 |
| 41 | myeloid dendritic cell activation (GO:0001773) | 5.26705275 |
| 42 | regulation of isotype switching (GO:0045191) | 5.24515191 |
| 43 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 5.21254578 |
| 44 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 5.17074728 |
| 45 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.01709461 |
| 46 | phosphorelay signal transduction system (GO:0000160) | 5.00853768 |
| 47 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.98518477 |
| 48 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 4.94346228 |
| 49 | positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531) | 4.93787115 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.92276218 |
| 51 | regulation of immunoglobulin secretion (GO:0051023) | 4.89766213 |
| 52 | metallo-sulfur cluster assembly (GO:0031163) | 4.79747225 |
| 53 | iron-sulfur cluster assembly (GO:0016226) | 4.79747225 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 4.73345351 |
| 55 | positive thymic T cell selection (GO:0045059) | 4.71800670 |
| 56 | oxygen transport (GO:0015671) | 4.57828816 |
| 57 | positive regulation of defense response to virus by host (GO:0002230) | 4.56526994 |
| 58 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.43963228 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.42745104 |
| 60 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.41964017 |
| 61 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 4.40771073 |
| 62 | mast cell activation involved in immune response (GO:0002279) | 4.32316680 |
| 63 | mast cell degranulation (GO:0043303) | 4.32316680 |
| 64 | regulation of tyrosine phosphorylation of STAT protein (GO:0042509) | 4.27836428 |
| 65 | * positive regulation of leukocyte mediated immunity (GO:0002705) | 4.23609043 |
| 66 | * positive regulation of cell killing (GO:0031343) | 4.21425951 |
| 67 | * positive regulation of immunoglobulin production (GO:0002639) | 4.20935975 |
| 68 | positive T cell selection (GO:0043368) | 4.19708801 |
| 69 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.16182900 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 4.13097359 |
| 71 | regulation of memory T cell differentiation (GO:0043380) | 4.12539302 |
| 72 | positive regulation of JAK-STAT cascade (GO:0046427) | 4.07439843 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 4.07034518 |
| 74 | cellular defense response (GO:0006968) | 4.06173239 |
| 75 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.05928316 |
| 76 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 4.03195145 |
| 77 | * regulation of lymphocyte mediated immunity (GO:0002706) | 4.02706555 |
| 78 | response to interleukin-15 (GO:0070672) | 4.00090832 |
| 79 | positive regulation of activated T cell proliferation (GO:0042104) | 3.96708101 |
| 80 | L-fucose catabolic process (GO:0042355) | 3.93644701 |
| 81 | fucose catabolic process (GO:0019317) | 3.93644701 |
| 82 | L-fucose metabolic process (GO:0042354) | 3.93644701 |
| 83 | T cell proliferation (GO:0042098) | 3.87111553 |
| 84 | regulation of gamma-delta T cell activation (GO:0046643) | 3.85598109 |
| 85 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.84771353 |
| 86 | * regulation of lymphocyte chemotaxis (GO:1901623) | 3.81581896 |
| 87 | mast cell activation (GO:0045576) | 3.78870803 |
| 88 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.75118760 |
| 89 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.72986912 |
| 90 | negative regulation of viral transcription (GO:0032897) | 3.72897311 |
| 91 | * regulation of immunoglobulin production (GO:0002637) | 3.72264625 |
| 92 | positive regulation of astrocyte differentiation (GO:0048711) | 3.66220582 |
| 93 | negative T cell selection (GO:0043383) | 3.66173903 |
| 94 | negative regulation of heart rate (GO:0010459) | 3.65366783 |
| 95 | lymph node development (GO:0048535) | 3.64358751 |
| 96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.63615824 |
| 97 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.63326428 |
| 98 | positive regulation of interleukin-17 production (GO:0032740) | 3.63301987 |
| 99 | positive regulation of organelle assembly (GO:1902117) | 3.62549512 |
| 100 | * regulation of cell killing (GO:0031341) | 3.62503253 |
| 101 | rRNA methylation (GO:0031167) | 3.60372119 |
| 102 | GDP-mannose metabolic process (GO:0019673) | 3.57713433 |
| 103 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.57444361 |
| 104 | cytokine production (GO:0001816) | 3.55535703 |
| 105 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.54281551 |
| 106 | termination of RNA polymerase III transcription (GO:0006386) | 3.54281551 |
| 107 | * positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.50560643 |
| 108 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.48727020 |
| 109 | regulation of defense response to virus by host (GO:0050691) | 3.47259587 |
| 110 | T cell receptor signaling pathway (GO:0050852) | 3.46964420 |
| 111 | * positive regulation of T cell chemotaxis (GO:0010820) | 3.44171917 |
| 112 | * regulation of T cell chemotaxis (GO:0010819) | 3.44171917 |
| 113 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.44115026 |
| 114 | dendritic cell differentiation (GO:0097028) | 3.42941980 |
| 115 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.38229809 |
| 116 | thymic T cell selection (GO:0045061) | 3.37221207 |
| 117 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.36774310 |
| 118 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.36722196 |
| 119 | negative thymic T cell selection (GO:0045060) | 3.36087272 |
| 120 | negative regulation of B cell apoptotic process (GO:0002903) | 3.31954352 |
| 121 | * positive regulation of adaptive immune response (GO:0002821) | 3.31539463 |
| 122 | Peyers patch development (GO:0048541) | 3.31509911 |
| 123 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.31509911 |
| 124 | inflammatory response to antigenic stimulus (GO:0002437) | 3.29283433 |
| 125 | negative regulation of cell killing (GO:0031342) | 3.29018354 |
| 126 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.29018354 |
| 127 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.26793632 |
| 128 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.25918095 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.25918095 |
| 130 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.25679825 |
| 131 | rRNA modification (GO:0000154) | 3.25252257 |
| 132 | cellular response to nicotine (GO:0071316) | 3.24752259 |
| 133 | positive regulation of interferon-gamma production (GO:0032729) | 3.20390118 |
| 134 | natural killer cell differentiation (GO:0001779) | 3.16728281 |
| 135 | T cell costimulation (GO:0031295) | 3.15415810 |
| 136 | T cell mediated immunity (GO:0002456) | 3.13408643 |
| 137 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.12005401 |
| 138 | defense response to protozoan (GO:0042832) | 3.10952315 |
| 139 | mRNA cleavage (GO:0006379) | 3.09902534 |
| 140 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.09312231 |
| 141 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08728120 |
| 142 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.08585987 |
| 143 | lymphocyte costimulation (GO:0031294) | 3.08254026 |
| 144 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.07962555 |
| 145 | regulation of interleukin-17 production (GO:0032660) | 3.07739418 |
| 146 | negative regulation of interleukin-12 production (GO:0032695) | 3.05656860 |
| 147 | natural killer cell activation (GO:0030101) | 3.04841649 |
| 148 | leukocyte aggregation (GO:0070486) | 3.02999365 |
| 149 | * positive regulation of T-helper 1 type immune response (GO:0002827) | 2.98705644 |
| 150 | * regulation of T-helper 1 type immune response (GO:0002825) | 2.95716192 |
| 151 | piRNA metabolic process (GO:0034587) | 2.94633953 |
| 152 | positive regulation of protein homodimerization activity (GO:0090073) | 2.93508919 |
| 153 | protein polyglutamylation (GO:0018095) | 2.87339177 |
| 154 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.86856925 |
| 155 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.86856925 |
| 156 | T cell differentiation involved in immune response (GO:0002292) | 2.86856925 |
| 157 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.84486570 |
| 158 | T-helper cell differentiation (GO:0042093) | 2.84486570 |
| 159 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84045056 |
| 160 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.77327496 |
| 161 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.77327496 |
| 162 | T cell migration (GO:0072678) | 2.76682529 |
| 163 | leukocyte degranulation (GO:0043299) | 2.72406084 |
| 164 | positive regulation of hormone metabolic process (GO:0032352) | 2.70637547 |
| 165 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 10.5414560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.88372283 |
| 2 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.16804922 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.04552973 |
| 4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 5.85148931 |
| 5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.60931629 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 4.24045657 |
| 7 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.73407311 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.43132229 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 3.42702626 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32363572 |
| 11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 3.19856989 |
| 12 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.13199389 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 3.08910511 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.08090888 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 3.07489335 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.04199189 |
| 17 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 2.95136377 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82784587 |
| 19 | MYB_26560356_Chip-Seq_TH2_Human | 2.81923044 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.70671625 |
| 21 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.69677330 |
| 22 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.64819278 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.56906688 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.37450413 |
| 25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.35828923 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.34377946 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.25575936 |
| 28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.23225664 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07340911 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.96744529 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96574419 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88793759 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88254834 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83618902 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.83294143 |
| 36 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.80054655 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.79602550 |
| 38 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68859545 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68704859 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.66569425 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.66536044 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61428828 |
| 43 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.59989220 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57433583 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57166250 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56037927 |
| 47 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.54230974 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52579709 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.52434147 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52426532 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51413798 |
| 52 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49727492 |
| 53 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48884814 |
| 54 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.48014444 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45154461 |
| 56 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44742271 |
| 57 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44556030 |
| 58 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42486473 |
| 59 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.41421589 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40762815 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.36826434 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36648097 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.35052682 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33340139 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32604465 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32286026 |
| 67 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30356073 |
| 68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.29648970 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.28645899 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.26542235 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26062403 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25385368 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24061411 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23983813 |
| 75 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23015899 |
| 76 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21326944 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20497814 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20013357 |
| 79 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.18882699 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17386449 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16756512 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14807430 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13964911 |
| 84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13791299 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13475885 |
| 86 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11905980 |
| 87 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.11357931 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09247517 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07418932 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06666008 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04219376 |
| 92 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04039576 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04039576 |
| 94 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02539940 |
| 95 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.01184273 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00806456 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.99729031 |
| 98 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98342343 |
| 99 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97501614 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96829641 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96751824 |
| 102 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.96558965 |
| 103 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.96250805 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.96215061 |
| 105 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.95400659 |
| 106 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94218651 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93605277 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93456282 |
| 109 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92667464 |
| 110 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92534070 |
| 111 | * HOXB7_26014856_ChIP-Seq_BT474_Human | 0.91949885 |
| 112 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.91045561 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90820802 |
| 114 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90182980 |
| 115 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90015384 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89313697 |
| 117 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88768818 |
| 118 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87834250 |
| 119 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87400603 |
| 120 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87371416 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87314279 |
| 122 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.87211754 |
| 123 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.86827389 |
| 124 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86370732 |
| 125 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.85268535 |
| 126 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84335444 |
| 127 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83922549 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.83307920 |
| 129 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.82379818 |
| 130 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.81970120 |
| 131 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.81096722 |
| 132 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80803925 |
| 133 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.79400247 |
| 134 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79109001 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78715543 |
| 136 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78661856 |
| 137 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.77503936 |
| 138 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75927563 |
| 139 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75546621 |
| 140 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.75386267 |
| 141 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75370789 |
| 142 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.75197716 |
| 143 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74567960 |
| 144 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.74195306 |
| 145 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.73597082 |
| 146 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73573547 |
| 147 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73547417 |
| 148 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.73426569 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73311211 |
| 150 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.73229357 |
| 151 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.73091951 |
| 152 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.72605508 |
| 153 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72477588 |
| 154 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.72192837 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69645382 |
| 156 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68850816 |
| 157 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.68576556 |
| 158 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.67773050 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67257974 |
| 160 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65056471 |
| 161 | GATA3_26560356_Chip-Seq_TH1_Human | 0.64641521 |
| 162 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64160046 |
| 163 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.62999524 |
| 164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.60396650 |
| 165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59387063 |
| 166 | ATF3_27146783_Chip-Seq_COLON_Human | 0.58416487 |
| 167 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58254602 |
| 168 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57978898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 5.26954359 |
| 2 | MP0005671_abnormal_response_to | 4.73859327 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.43102686 |
| 4 | MP0003436_decreased_susceptibility_to | 4.41893863 |
| 5 | MP0004782_abnormal_surfactant_physiolog | 4.28313635 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.61501607 |
| 7 | MP0001958_emphysema | 3.51322541 |
| 8 | MP0009785_altered_susceptibility_to | 3.44951433 |
| 9 | MP0002405_respiratory_system_inflammati | 3.30367689 |
| 10 | MP0000685_abnormal_immune_system | 3.20937065 |
| 11 | MP0006082_CNS_inflammation | 3.08343649 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.83856509 |
| 13 | MP0003646_muscle_fatigue | 2.83844209 |
| 14 | MP0001853_heart_inflammation | 2.81718626 |
| 15 | MP0001800_abnormal_humoral_immune | 2.76227912 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.65586802 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.56659104 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.52209697 |
| 19 | MP0003866_abnormal_defecation | 2.51497572 |
| 20 | MP0005025_abnormal_response_to | 2.24284655 |
| 21 | MP0002723_abnormal_immune_serum | 2.23897082 |
| 22 | MP0001873_stomach_inflammation | 2.19440870 |
| 23 | MP0001819_abnormal_immune_cell | 2.10703898 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.09495695 |
| 25 | MP0000604_amyloidosis | 2.07868489 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.05320909 |
| 27 | MP0002398_abnormal_bone_marrow | 2.04873281 |
| 28 | MP0003303_peritoneal_inflammation | 2.03766871 |
| 29 | MP0000613_abnormal_salivary_gland | 2.03082167 |
| 30 | MP0002132_abnormal_respiratory_system | 2.00836940 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.89016500 |
| 32 | MP0002396_abnormal_hematopoietic_system | 1.81667549 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.81297165 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.80426213 |
| 35 | MP0004510_myositis | 1.78923131 |
| 36 | MP0001790_abnormal_immune_system | 1.77122401 |
| 37 | MP0005387_immune_system_phenotype | 1.77122401 |
| 38 | MP0002166_altered_tumor_susceptibility | 1.73408765 |
| 39 | MP0001881_abnormal_mammary_gland | 1.68991322 |
| 40 | MP0002722_abnormal_immune_system | 1.68492052 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.67078970 |
| 42 | MP0000716_abnormal_immune_system | 1.66689352 |
| 43 | MP0003045_fibrosis | 1.65712685 |
| 44 | MP0002006_tumorigenesis | 1.64975786 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.63784607 |
| 46 | MP0004947_skin_inflammation | 1.62564839 |
| 47 | MP0000569_abnormal_digit_pigmentation | 1.59524245 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.48190040 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.47864785 |
| 50 | MP0005075_abnormal_melanosome_morpholog | 1.44436383 |
| 51 | MP0002419_abnormal_innate_immunity | 1.43776699 |
| 52 | MP0001661_extended_life_span | 1.42838021 |
| 53 | MP0009764_decreased_sensitivity_to | 1.40175847 |
| 54 | MP0005165_increased_susceptibility_to | 1.39729710 |
| 55 | MP0008057_abnormal_DNA_replication | 1.35107202 |
| 56 | MP0005451_abnormal_body_composition | 1.34309765 |
| 57 | MP0002429_abnormal_blood_cell | 1.33330068 |
| 58 | MP0010234_abnormal_vibrissa_follicle | 1.32166091 |
| 59 | MP0003448_altered_tumor_morphology | 1.31267262 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.29993473 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.28893014 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.28771832 |
| 63 | MP0000372_irregular_coat_pigmentation | 1.26342007 |
| 64 | MP0008872_abnormal_physiological_respon | 1.24659986 |
| 65 | MP0003786_premature_aging | 1.22902968 |
| 66 | MP0004142_abnormal_muscle_tone | 1.20013142 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.18341935 |
| 68 | MP0010307_abnormal_tumor_latency | 1.16254445 |
| 69 | MP0000627_abnormal_mammary_gland | 1.13141043 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.07724099 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 0.94712578 |
| 72 | MP0000609_abnormal_liver_physiology | 0.92371298 |
| 73 | MP0004808_abnormal_hematopoietic_stem | 0.88534885 |
| 74 | MP0004381_abnormal_hair_follicle | 0.88527224 |
| 75 | MP0002009_preneoplasia | 0.86568354 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.86508576 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.85639579 |
| 78 | MP0000490_abnormal_crypts_of | 0.84779917 |
| 79 | MP0001851_eye_inflammation | 0.84287890 |
| 80 | MP0000858_altered_metastatic_potential | 0.84226861 |
| 81 | MP0004742_abnormal_vestibular_system | 0.83888977 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.83381964 |
| 83 | MP0008877_abnormal_DNA_methylation | 0.83129966 |
| 84 | MP0003705_abnormal_hypodermis_morpholog | 0.81115636 |
| 85 | MP0005166_decreased_susceptibility_to | 0.81073818 |
| 86 | MP0003724_increased_susceptibility_to | 0.79865846 |
| 87 | MP0002019_abnormal_tumor_incidence | 0.79615833 |
| 88 | MP0000015_abnormal_ear_pigmentation | 0.78813984 |
| 89 | MP0002933_joint_inflammation | 0.78469542 |
| 90 | MP0008469_abnormal_protein_level | 0.77721066 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.77086185 |
| 92 | MP0000358_abnormal_cell_content/ | 0.73813769 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.72904190 |
| 94 | MP0003878_abnormal_ear_physiology | 0.72077903 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.72077903 |
| 96 | MP0003195_calcinosis | 0.71312277 |
| 97 | MP0009763_increased_sensitivity_to | 0.70715810 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.70609965 |
| 99 | MP0001485_abnormal_pinna_reflex | 0.70607926 |
| 100 | MP0002254_reproductive_system_inflammat | 0.70231626 |
| 101 | MP0001727_abnormal_embryo_implantation | 0.69480461 |
| 102 | MP0005390_skeleton_phenotype | 0.69345884 |
| 103 | MP0005076_abnormal_cell_differentiation | 0.68157215 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.66825298 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.64821767 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.62171164 |
| 107 | MP0002998_abnormal_bone_remodeling | 0.58579560 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.57348416 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.56893066 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.55730559 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.53339756 |
| 112 | MP0003959_abnormal_lean_body | 0.53129402 |
| 113 | MP0004130_abnormal_muscle_cell | 0.53033619 |
| 114 | MP0005647_abnormal_sex_gland | 0.51362698 |
| 115 | MP0005410_abnormal_fertilization | 0.49469875 |
| 116 | MP0006276_abnormal_autonomic_nervous | 0.48568200 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.48391131 |
| 118 | MP0000249_abnormal_blood_vessel | 0.47227040 |
| 119 | MP0001663_abnormal_digestive_system | 0.47190503 |
| 120 | MP0009745_abnormal_behavioral_response | 0.46160206 |
| 121 | MP0009643_abnormal_urine_homeostasis | 0.45964681 |
| 122 | MP0004885_abnormal_endolymph | 0.45528384 |
| 123 | MP0001919_abnormal_reproductive_system | 0.45372198 |
| 124 | MP0005448_abnormal_energy_balance | 0.45329457 |
| 125 | MP0003252_abnormal_bile_duct | 0.45195199 |
| 126 | MP0003936_abnormal_reproductive_system | 0.45001616 |
| 127 | MP0005253_abnormal_eye_physiology | 0.44512911 |
| 128 | MP0009046_muscle_twitch | 0.43986267 |
| 129 | MP0000003_abnormal_adipose_tissue | 0.43683736 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.43228322 |
| 131 | MP0005257_abnormal_intraocular_pressure | 0.42932508 |
| 132 | MP0004484_altered_response_of | 0.42654084 |
| 133 | MP0000598_abnormal_liver_morphology | 0.42585686 |
| 134 | MP0002877_abnormal_melanocyte_morpholog | 0.42102470 |
| 135 | MP0005388_respiratory_system_phenotype | 0.41489670 |
| 136 | MP0002133_abnormal_respiratory_system | 0.41489670 |
| 137 | MP0002796_impaired_skin_barrier | 0.39752940 |
| 138 | MP0005501_abnormal_skin_physiology | 0.38137459 |
| 139 | MP0003943_abnormal_hepatobiliary_system | 0.37915614 |
| 140 | MP0000367_abnormal_coat/_hair | 0.35940081 |
| 141 | MP0005310_abnormal_salivary_gland | 0.34772850 |
| 142 | MP0008569_lethality_at_weaning | 0.33266294 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.33260310 |
| 144 | MP0010352_gastrointestinal_tract_polyps | 0.32754354 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 9.88299568 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 8.86107295 |
| 3 | T lymphocytopenia (HP:0005403) | 7.27730477 |
| 4 | Abnormality of T cell number (HP:0011839) | 7.10977790 |
| 5 | Nasal polyposis (HP:0100582) | 6.12679912 |
| 6 | Autoimmune hemolytic anemia (HP:0001890) | 5.36695971 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 5.05751045 |
| 8 | Abnormality of the labia minora (HP:0012880) | 4.43730850 |
| 9 | Abnormality of T cells (HP:0002843) | 4.36316508 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.34757325 |
| 11 | Joint swelling (HP:0001386) | 4.01477931 |
| 12 | Keratitis (HP:0000491) | 3.97032824 |
| 13 | Chronic diarrhea (HP:0002028) | 3.85957556 |
| 14 | Recurrent viral infections (HP:0004429) | 3.83968938 |
| 15 | Severe combined immunodeficiency (HP:0004430) | 3.81264171 |
| 16 | Thrombocytosis (HP:0001894) | 3.77717379 |
| 17 | IgG deficiency (HP:0004315) | 3.75884013 |
| 18 | Increased density of long bones (HP:0006392) | 3.75413437 |
| 19 | Hypoplastic ischia (HP:0003175) | 3.66815116 |
| 20 | Arterial thrombosis (HP:0004420) | 3.63562235 |
| 21 | 3-Methylglutaconic aciduria (HP:0003535) | 3.63517741 |
| 22 | Anorexia (HP:0002039) | 3.59192028 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.41113833 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.39495402 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.37527487 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.33937119 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.33937119 |
| 28 | Combined immunodeficiency (HP:0005387) | 3.25145419 |
| 29 | Slow saccadic eye movements (HP:0000514) | 3.24026225 |
| 30 | Submucous cleft hard palate (HP:0000176) | 3.15626005 |
| 31 | Persistence of primary teeth (HP:0006335) | 3.10939050 |
| 32 | Abnormality of the ischium (HP:0003174) | 3.03616595 |
| 33 | Myositis (HP:0100614) | 3.00482463 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.96929668 |
| 35 | Optic neuritis (HP:0100653) | 2.96929668 |
| 36 | IgA deficiency (HP:0002720) | 2.94167046 |
| 37 | Cerebral hypomyelination (HP:0006808) | 2.91334903 |
| 38 | Septate vagina (HP:0001153) | 2.89992944 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.85278717 |
| 40 | Orchitis (HP:0100796) | 2.81024156 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.78019124 |
| 42 | Abnormality of the endocardium (HP:0004306) | 2.76625156 |
| 43 | Chest pain (HP:0100749) | 2.76265991 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 2.75950927 |
| 45 | Amaurosis fugax (HP:0100576) | 2.75073246 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.72975150 |
| 47 | Lymphoma (HP:0002665) | 2.71837735 |
| 48 | Recurrent bronchitis (HP:0002837) | 2.68796308 |
| 49 | Abnormality of lateral ventricle (HP:0030047) | 2.68067726 |
| 50 | Diplopia (HP:0000651) | 2.67241083 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.67241083 |
| 52 | Acne (HP:0001061) | 2.67233397 |
| 53 | Impaired smooth pursuit (HP:0007772) | 2.64958191 |
| 54 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.64681130 |
| 55 | Abnormality of the nasal septum (HP:0000419) | 2.63832802 |
| 56 | Prominent nose (HP:0000448) | 2.59938223 |
| 57 | Abnormality of the pleura (HP:0002103) | 2.58392771 |
| 58 | Sparse scalp hair (HP:0002209) | 2.51096627 |
| 59 | Chronic otitis media (HP:0000389) | 2.49913381 |
| 60 | Myocardial infarction (HP:0001658) | 2.48697404 |
| 61 | Lip pit (HP:0100267) | 2.48670414 |
| 62 | Abnormality of the pericardium (HP:0001697) | 2.46343904 |
| 63 | Menstrual irregularities (HP:0000858) | 2.46082138 |
| 64 | Polyneuropathy (HP:0001271) | 2.45922040 |
| 65 | Oligodontia (HP:0000677) | 2.45202015 |
| 66 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.44549774 |
| 67 | Parakeratosis (HP:0001036) | 2.41186996 |
| 68 | Peritonitis (HP:0002586) | 2.38118297 |
| 69 | Glomerulopathy (HP:0100820) | 2.37346054 |
| 70 | Horizontal nystagmus (HP:0000666) | 2.30097677 |
| 71 | Esophageal varix (HP:0002040) | 2.29466637 |
| 72 | Lymphopenia (HP:0001888) | 2.28288025 |
| 73 | Abnormal number of erythroid precursors (HP:0012131) | 2.26811410 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25228460 |
| 75 | Cutaneous melanoma (HP:0012056) | 2.25113362 |
| 76 | Pancreatitis (HP:0001733) | 2.24164453 |
| 77 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.23790186 |
| 78 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.23495188 |
| 79 | Pulmonary embolism (HP:0002204) | 2.23007692 |
| 80 | Type I transferrin isoform profile (HP:0003642) | 2.21345365 |
| 81 | Agammaglobulinemia (HP:0004432) | 2.20599405 |
| 82 | Leukocytosis (HP:0001974) | 2.18228564 |
| 83 | Aplasia cutis congenita (HP:0001057) | 2.15670411 |
| 84 | Premature graying of hair (HP:0002216) | 2.15208392 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.13772621 |
| 86 | Abnormality of the peritoneum (HP:0002585) | 2.13038189 |
| 87 | Vasculitis (HP:0002633) | 2.09522361 |
| 88 | Thrombophlebitis (HP:0004418) | 2.09487887 |
| 89 | Fetal akinesia sequence (HP:0001989) | 2.07855830 |
| 90 | Portal hypertension (HP:0001409) | 2.07024428 |
| 91 | 2-3 toe syndactyly (HP:0004691) | 2.05447247 |
| 92 | Polycythemia (HP:0001901) | 2.05317999 |
| 93 | Pancytopenia (HP:0001876) | 2.05308244 |
| 94 | Megalencephaly (HP:0001355) | 2.05113266 |
| 95 | Duplicated collecting system (HP:0000081) | 2.04066000 |
| 96 | Fatigue (HP:0012378) | 2.03720436 |
| 97 | Somatic mutation (HP:0001428) | 2.03587226 |
| 98 | Dysautonomia (HP:0002459) | 2.02402360 |
| 99 | Abnormality of T cell physiology (HP:0011840) | 2.00041554 |
| 100 | Abnormality of oral frenula (HP:0000190) | 1.99407124 |
| 101 | Increased intracranial pressure (HP:0002516) | 1.98009319 |
| 102 | Abnormality of intracranial pressure (HP:0012640) | 1.98009319 |
| 103 | Keratoconjunctivitis sicca (HP:0001097) | 1.97525445 |
| 104 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97093287 |
| 105 | Amniotic constriction ring (HP:0009775) | 1.96429009 |
| 106 | Abnormality of placental membranes (HP:0011409) | 1.96429009 |
| 107 | Memory impairment (HP:0002354) | 1.95805711 |
| 108 | Fair hair (HP:0002286) | 1.95213864 |
| 109 | Gingival bleeding (HP:0000225) | 1.95153391 |
| 110 | Spontaneous abortion (HP:0005268) | 1.95012098 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 1.93604408 |
| 112 | Abnormal protein glycosylation (HP:0012346) | 1.92409533 |
| 113 | Abnormal glycosylation (HP:0012345) | 1.92409533 |
| 114 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92409533 |
| 115 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92409533 |
| 116 | Meningitis (HP:0001287) | 1.91868240 |
| 117 | Conical tooth (HP:0000698) | 1.91771002 |
| 118 | Acrocyanosis (HP:0001063) | 1.91689250 |
| 119 | Hepatocellular necrosis (HP:0001404) | 1.91071952 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.90956066 |
| 121 | Subacute progressive viral hepatitis (HP:0006572) | 1.89053108 |
| 122 | Thoracolumbar scoliosis (HP:0002944) | 1.88944681 |
| 123 | Abnormality of saccadic eye movements (HP:0000570) | 1.87130899 |
| 124 | Abnormal number of incisors (HP:0011064) | 1.85504783 |
| 125 | Abnormality of eosinophils (HP:0001879) | 1.85105151 |
| 126 | Gangrene (HP:0100758) | 1.84164744 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.82938152 |
| 128 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82938152 |
| 129 | Adactyly (HP:0009776) | 1.82637938 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.82296786 |
| 131 | Abnormality of the hepatic vasculature (HP:0006707) | 1.82068813 |
| 132 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.81520629 |
| 133 | Arthralgia (HP:0002829) | 1.79986896 |
| 134 | Encephalitis (HP:0002383) | 1.79428357 |
| 135 | Acute myeloid leukemia (HP:0004808) | 1.78607186 |
| 136 | Abnormality of the Achilles tendon (HP:0005109) | 1.78233439 |
| 137 | Generalized hypopigmentation of hair (HP:0011358) | 1.77883435 |
| 138 | Achilles tendon contracture (HP:0001771) | 1.77009695 |
| 139 | Abnormality of the renal collecting system (HP:0004742) | 1.76955384 |
| 140 | Thyroiditis (HP:0100646) | 1.76742596 |
| 141 | Orthostatic hypotension (HP:0001278) | 1.76596448 |
| 142 | Keratoconjunctivitis (HP:0001096) | 1.72469806 |
| 143 | Gaze-evoked nystagmus (HP:0000640) | 1.72385037 |
| 144 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.71252066 |
| 145 | Abnormality of the pons (HP:0007361) | 1.70632218 |
| 146 | Abnormality of the clitoris (HP:0000056) | 1.70531045 |
| 147 | Cerebral ischemia (HP:0002637) | 1.69490092 |
| 148 | Molar tooth sign on MRI (HP:0002419) | 1.69412973 |
| 149 | Abnormality of midbrain morphology (HP:0002418) | 1.69412973 |
| 150 | Aseptic necrosis (HP:0010885) | 1.68289072 |
| 151 | Hypoproteinemia (HP:0003075) | 1.68122850 |
| 152 | IgM deficiency (HP:0002850) | 1.67617303 |
| 153 | Acute hepatic failure (HP:0006554) | 1.66997774 |
| 154 | Anhidrosis (HP:0000970) | 1.66983290 |
| 155 | Eosinophilia (HP:0001880) | 1.66197576 |
| 156 | Cerebral hemorrhage (HP:0001342) | 1.66027458 |
| 157 | Renal cortical cysts (HP:0000803) | 1.65529443 |
| 158 | Entropion (HP:0000621) | 1.64877143 |
| 159 | Vertigo (HP:0002321) | 1.64154124 |
| 160 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.63032354 |
| 161 | Dyschromatopsia (HP:0007641) | 1.62109215 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.62049360 |
| 163 | Abnormality of the pubic bones (HP:0003172) | 1.61255847 |
| 164 | Hemoptysis (HP:0002105) | 1.59424256 |
| 165 | Abnormality of the common coagulation pathway (HP:0010990) | 1.58959560 |
| 166 | Hypoplasia of the thymus (HP:0000778) | 1.58908584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NEK9 | 8.24750359 |
| 2 | TXK | 7.03805308 |
| 3 | MAP4K1 | 6.22020918 |
| 4 | ITK | 4.87263640 |
| 5 | PIM2 | 4.40132165 |
| 6 | ZAP70 | 3.25283665 |
| 7 | TEC | 3.09946743 |
| 8 | CDK3 | 2.78729866 |
| 9 | CSK | 2.68799374 |
| 10 | JAK3 | 2.51355703 |
| 11 | MAP3K14 | 2.40483297 |
| 12 | EEF2K | 2.31543510 |
| 13 | TAOK3 | 2.17987899 |
| 14 | NLK | 2.16062104 |
| 15 | EPHA3 | 2.07608292 |
| 16 | RAF1 | 1.86100222 |
| 17 | MATK | 1.84968511 |
| 18 | BTK | 1.77029409 |
| 19 | WNK4 | 1.71387366 |
| 20 | TAOK1 | 1.60981296 |
| 21 | ZAK | 1.60791476 |
| 22 | HCK | 1.56599228 |
| 23 | PIM1 | 1.49975657 |
| 24 | DAPK1 | 1.49133727 |
| 25 | LCK | 1.46275476 |
| 26 | CHUK | 1.44088600 |
| 27 | MAP2K6 | 1.42632410 |
| 28 | IKBKB | 1.40492760 |
| 29 | NTRK1 | 1.35593586 |
| 30 | FGFR4 | 1.35058151 |
| 31 | MAP4K2 | 1.34483741 |
| 32 | MAP3K3 | 1.31712228 |
| 33 | MST4 | 1.19887468 |
| 34 | MAP3K11 | 1.19555720 |
| 35 | PAK2 | 1.17782162 |
| 36 | STK10 | 1.13574327 |
| 37 | GSK3A | 1.12861880 |
| 38 | MAP3K7 | 1.12276133 |
| 39 | TYK2 | 1.12024060 |
| 40 | MAPK11 | 1.12016121 |
| 41 | SYK | 1.10521209 |
| 42 | CAMKK2 | 1.07552747 |
| 43 | PIK3CG | 1.04734504 |
| 44 | TBK1 | 1.03859331 |
| 45 | LRRK2 | 1.03793320 |
| 46 | TSSK6 | 1.02624336 |
| 47 | EIF2AK2 | 0.95498244 |
| 48 | RPS6KA4 | 0.94319735 |
| 49 | FGFR3 | 0.91573343 |
| 50 | LYN | 0.91367046 |
| 51 | IKBKE | 0.90322796 |
| 52 | PRKCH | 0.89352217 |
| 53 | RPS6KB2 | 0.85006037 |
| 54 | EIF2AK3 | 0.84647457 |
| 55 | MAP3K13 | 0.81434794 |
| 56 | ALK | 0.80026834 |
| 57 | STK39 | 0.79221449 |
| 58 | MST1R | 0.78559176 |
| 59 | CLK1 | 0.77676835 |
| 60 | NUAK1 | 0.76024142 |
| 61 | TLK1 | 0.75979208 |
| 62 | TRIB3 | 0.75137733 |
| 63 | ADRBK2 | 0.74259296 |
| 64 | INSR | 0.73364963 |
| 65 | TYRO3 | 0.72833496 |
| 66 | PINK1 | 0.72443346 |
| 67 | FGFR1 | 0.71346240 |
| 68 | IRAK1 | 0.67134653 |
| 69 | MAP2K2 | 0.63849268 |
| 70 | NTRK2 | 0.63797666 |
| 71 | FES | 0.63661516 |
| 72 | GRK7 | 0.59760788 |
| 73 | PRKCQ | 0.59508211 |
| 74 | JAK1 | 0.58669054 |
| 75 | PRKCG | 0.57918561 |
| 76 | TAOK2 | 0.57776099 |
| 77 | MAP3K12 | 0.57514489 |
| 78 | PIK3CA | 0.57058542 |
| 79 | ACVR1B | 0.56912355 |
| 80 | MAP3K1 | 0.56149121 |
| 81 | NEK1 | 0.54760846 |
| 82 | FER | 0.54116966 |
| 83 | VRK2 | 0.53040175 |
| 84 | CSNK1D | 0.52727444 |
| 85 | YES1 | 0.52600277 |
| 86 | PHKG2 | 0.52183416 |
| 87 | PHKG1 | 0.52183416 |
| 88 | EGFR | 0.52080984 |
| 89 | FRK | 0.51466502 |
| 90 | IGF1R | 0.50063378 |
| 91 | NME1 | 0.48227063 |
| 92 | MAPK7 | 0.47798924 |
| 93 | KIT | 0.46977914 |
| 94 | JAK2 | 0.46405362 |
| 95 | MARK3 | 0.45746379 |
| 96 | MAP3K8 | 0.44100776 |
| 97 | MARK2 | 0.43384625 |
| 98 | PASK | 0.42504153 |
| 99 | MUSK | 0.40182835 |
| 100 | MAP2K3 | 0.39239455 |
| 101 | ERN1 | 0.38791644 |
| 102 | ROCK2 | 0.37053331 |
| 103 | CAMKK1 | 0.36927834 |
| 104 | RPS6KA1 | 0.36289666 |
| 105 | MAP3K5 | 0.35878289 |
| 106 | NME2 | 0.34308857 |
| 107 | RPS6KA5 | 0.34031807 |
| 108 | EIF2AK1 | 0.33973320 |
| 109 | PTK6 | 0.33294338 |
| 110 | MAP3K9 | 0.32766107 |
| 111 | PRKCE | 0.32680031 |
| 112 | CSNK1A1L | 0.31745812 |
| 113 | MAP3K2 | 0.30749888 |
| 114 | MAPKAPK2 | 0.30688691 |
| 115 | MAP3K10 | 0.30107166 |
| 116 | BMPR2 | 0.29793230 |
| 117 | FYN | 0.29720764 |
| 118 | IRAK4 | 0.29535868 |
| 119 | FGFR2 | 0.29047611 |
| 120 | CDK4 | 0.28275735 |
| 121 | MELK | 0.28153705 |
| 122 | RPS6KB1 | 0.27332050 |
| 123 | CSNK1G2 | 0.27209173 |
| 124 | TGFBR1 | 0.27198900 |
| 125 | MAPKAPK3 | 0.27170270 |
| 126 | EPHB1 | 0.26724746 |
| 127 | PRKCB | 0.26455775 |
| 128 | PKN1 | 0.25995520 |
| 129 | NEK6 | 0.25798817 |
| 130 | TGFBR2 | 0.25058098 |
| 131 | PDK1 | 0.24756946 |
| 132 | SRPK1 | 0.24722309 |
| 133 | BMX | 0.24208633 |
| 134 | PRKD1 | 0.23976844 |
| 135 | PDGFRB | 0.22506218 |
| 136 | KDR | 0.22264540 |
| 137 | ABL1 | 0.20462007 |
| 138 | MAPK9 | 0.17934898 |
| 139 | TNK2 | 0.17272444 |
| 140 | CSF1R | 0.16202021 |
| 141 | CDK19 | 0.16048226 |
| 142 | CSNK1G3 | 0.15976065 |
| 143 | GRK6 | 0.15393805 |
| 144 | CSNK2A2 | 0.14954413 |
| 145 | HIPK2 | 0.13330894 |
| 146 | WNK1 | 0.11475298 |
| 147 | CSNK1A1 | 0.09625538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 8.68368866 |
| 2 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 5.43035997 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 4.78969747 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.50850455 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.27379922 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.18157746 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.02639243 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.70363361 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.70332331 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.68847087 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.55345011 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 2.36687443 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15275692 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.12926055 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 2.11224129 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.09475994 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84947420 |
| 18 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.79961425 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.76245555 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.73261692 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54736499 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52145845 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.44751269 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.40600619 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.32942452 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.30449659 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30045735 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.25209368 |
| 29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15073141 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14520639 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.09693991 |
| 32 | Amoebiasis_Homo sapiens_hsa05146 | 1.06774159 |
| 33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01626671 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.01431213 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.00840957 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.00112186 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99865725 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92456289 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92228747 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.92198924 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92102078 |
| 42 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.85857566 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.84839462 |
| 44 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.81340214 |
| 45 | Homologous recombination_Homo sapiens_hsa03440 | 0.81315500 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77772161 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77749212 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.75488670 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74708987 |
| 50 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72200935 |
| 51 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71799872 |
| 52 | Purine metabolism_Homo sapiens_hsa00230 | 0.67525501 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65862699 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.64833135 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64010000 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.62188509 |
| 57 | Ribosome_Homo sapiens_hsa03010 | 0.60658948 |
| 58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.58642602 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56173366 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55723617 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.54396322 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54337473 |
| 63 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52941976 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.52761562 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.52259701 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51697831 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51582636 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.51073416 |
| 69 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51011125 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50903572 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50866645 |
| 72 | Legionellosis_Homo sapiens_hsa05134 | 0.50113234 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.49738716 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.49243424 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.49156691 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47352562 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46054540 |
| 78 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.46039441 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45542703 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45261811 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45093583 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44632230 |
| 83 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43499836 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.43035046 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42918136 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42096106 |
| 87 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41729291 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38786590 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38648534 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38133287 |
| 91 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.37907409 |
| 92 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37379505 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37120985 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.36480536 |
| 95 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35595159 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.35029491 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34124857 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.34050929 |
| 99 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.32090691 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.30972037 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30640436 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29837827 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29794206 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.26059220 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24289019 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.24107688 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.24037404 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.23873054 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22710602 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.22226990 |
| 111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.19493612 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19457746 |
| 113 | Platelet activation_Homo sapiens_hsa04611 | 0.18411759 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18402723 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16717331 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.16626729 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.15850086 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14844863 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14322441 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.14309082 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14279827 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14086107 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.13835181 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.13526983 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.13036932 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.12054353 |
| 127 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.11559220 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.11048478 |
| 129 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.10452655 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09551998 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.09402997 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.08253342 |
| 133 | Renin secretion_Homo sapiens_hsa04924 | 0.08120618 |
| 134 | Olfactory transduction_Homo sapiens_hsa04740 | 0.07354633 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.07046877 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | 0.05471471 |
| 137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03163900 |
| 138 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.02722250 |
| 139 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.02658454 |
| 140 | RNA polymerase_Homo sapiens_hsa03020 | 0.02568935 |
| 141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.02080089 |
| 142 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00787238 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.00741628 |
| 144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0412308 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | -0.0379754 |
| 146 | p53 signaling pathway_Homo sapiens_hsa04115 | -0.0358648 |
| 147 | Endocytosis_Homo sapiens_hsa04144 | -0.0340619 |
| 148 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0333425 |
| 149 | Spliceosome_Homo sapiens_hsa03040 | -0.0207607 |
| 150 | RNA transport_Homo sapiens_hsa03013 | -0.0026946 |
| 151 | Rap1 signaling pathway_Homo sapiens_hsa04015 | -0.0011926 |

